Metyrapone from Germany
Metyrapone, containing a methyl 1-(2-pyridyl)-1-propanone structure, inhibits cortisol synthesis in Cushing's syndrome treatment. HTS 2933.39.41.00 applies for its pyridine ring as a drug per Chapter 29 heterocyclic rules. Pharmaceutical bulk powder for API synthesis.
Duty Rate — Germany → United States
10%
Rate breakdown
9903.05.3910%Section 301 (forced labor) — European Union member state (col1 rate < 10 percent): MFN < 10% → total duty capped at 10%
Import Tips
• Ketone functionality confirmation via IR spectroscopy supporting pyridine classification
• Specify diagnostic/therapeutic end-use to avoid research chemical reclassification
• Light-sensitive powder; transport in amber containers with stability data